Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 11/20 | 0.42 |
| ▸ | P4HB | P07237 | 1/20 | 0.41 |
| ▸ | LIPG | Q9Y5X9 | 3/20 | 0.39 |
| ▸ | LPL | P06858 | 2/20 | 0.39 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 2/20 | 0.36 |
| ▸ | CA2 | P00918 | 2/20 | 0.36 |
| ▸ | CA9 | Q16790 | 2/20 | 0.36 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.35 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.35 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.34 |
| ▸ | KDR | P35968 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13855295 | 0.95 | PDK2 (0.45) | PDK2P4HBLIPGLPLROCK1 | |
| SCHEMBL12802176 | 0.88 | LPL (0.49) | P4HBLIPGLPLROCK1CA1 | |
| SCHEMBL17401217 | 0.88 | LPL (0.49) | P4HBLIPGLPLROCK1CA1 | |
| SCHEMBL29511660 | 0.88 | LPL (0.49) | P4HBLIPGLPLROCK1CA1 | |
| SCHEMBL12181997 | 0.88 | LPL (0.49) | P4HBLIPGLPLROCK1CA1 | |
| SCHEMBL19164440 | 0.87 | LPL (0.47) | P4HBLIPGLPLROCK1CA1 | |
| SCHEMBL19164658 | 0.87 | LPL (0.47) | P4HBLIPGLPLROCK1CA1 | |
| SCHEMBL17816719 | 0.87 | LPL (0.47) | P4HBLIPGLPLROCK1CA1 | |
| SCHEMBL21995589 | 0.84 | LPL (0.45) | P4HBLIPGLPLROCK1CA1 | |
| SCHEMBL21380081 | 0.81 | LPL (0.47) | P4HBLIPGLPLROCK1CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9871213-B2 | Organic electroluminescent device | MERCK PATENT GMBH (DE) | 2018-01-16 | — | — | US | disclosed |
| US-9871213-B2 | Organic electroluminescent device | MERCK PATENT GMBH (DE) | 2018-01-16 | — | — | US | disclosed |
| US-20160322570-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | MERCK PATENT GMBH (DE) | 2016-11-03 | — | — | US | disclosed |
| US-20160322570-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | MERCK PATENT GMBH (DE) | 2016-11-03 | — | — | US | disclosed |
| US-9403849-B2 | Organic electroluminescent device and boric acid and borinic acid derivatives used therein | MERCK PATENT GMBH (DE) | 2016-08-02 | — | — | US | disclosed |
| US-9403849-B2 | Organic electroluminescent device and boric acid and borinic acid derivatives used therein | MERCK PATENT GMBH (DE) | 2016-08-02 | — | — | US | disclosed |
| US-20150322091-A1 | ORGANIC ELECTROLUMINESCENT DEVICE AND BORIC ACID AND BORINIC ACID DERIVATIVES USED THEREIN | MERCK PATENT GMBH (DE) | 2015-11-12 | — | — | US | disclosed |
| US-20150322091-A1 | ORGANIC ELECTROLUMINESCENT DEVICE AND BORIC ACID AND BORINIC ACID DERIVATIVES USED THEREIN | MERCK PATENT GMBH (DE) | 2015-11-12 | — | — | US | disclosed |
| US-8674141-B2 | Organic electroluminescent device and boric acid and borinic acid derivatives used therein | MERCK PATENT GMBH (DE) | 2014-03-18 | — | — | US | disclosed |
| US-8674141-B2 | Organic electroluminescent device and boric acid and borinic acid derivatives used therein | MERCK PATENT GMBH (DE) | 2014-03-18 | — | — | US | disclosed |
| US-20090134384-A1 | ORGANIC ELECTROLUMINESCENT DEVICE AND BORIC ACID AND BORINIC ACID DERIVATIVES USED THEREIN | MERCK PATENT GMBH (DE) | 2009-05-28 | — | — | US | disclosed |
| US-20090134384-A1 | ORGANIC ELECTROLUMINESCENT DEVICE AND BORIC ACID AND BORINIC ACID DERIVATIVES USED THEREIN | MERCK PATENT GMBH (DE) | 2009-05-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090134384-A1 | ORGANIC ELECTROLUMINESCENT DEVICE AND BORIC ACID AND BORINIC ACID DERIVATIVES USED THEREIN | BTD, ERG, OR10J3 | PDK2 955/4885P4HB 3871/4885LIPG 2769/4885 |
| US-20160322570-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | OR10J3, BTD, ERG | PDK2 1562/4885P4HB 3554/4885LIPG 2564/4885 |
| US-20150322091-A1 | ORGANIC ELECTROLUMINESCENT DEVICE AND BORIC ACID AND BORINIC ACID DERIVATIVES USED THEREIN | BTD, ERG, OR10J3 | PDK2 955/4885P4HB 3871/4885LIPG 2769/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.